Cytokinetics, IncorporatedCYTKNASDAQ

Overview Intelligence Charts News Fundamentals Key Metrics Financials Growth Insiders

Loading chart...

Prev Close

60.72

Day Range

60.01-62.49

Volume

2.0M

Market Cap

7.6B

P/E

-9.9

52-Week Range29-71

29.31Current 62.2770.98

Alerts

Quick Start

1. Track CYTK with alerts 2. Compare CYTK vs SPY 3. Open key fundamentals chart

Want to monitor CYTK?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor CYTK

Key Statistics

Volume Distribution

About

cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. as a leader in muscle biology and the mechanics of muscle performance, we're developing small molecule drug candidates specifically engineered to increase muscle function and contractility.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Robert Blum

cytokinetics.com/ →